ATP synthase is a molecular machine embedded in cell membranes that produces adenosine triphosphate (ATP), the molecule your cells use as their primary energy currency. It works like a tiny turbine: protons (hydrogen ions) flow through it, spinning a rotor that drives the chemical assembly of ATP from its two building blocks, ADP and inorganic phosphate. This single enzyme is responsible for generating the vast majority of the ATP your body uses, roughly your own body weight in ATP every day.
How ATP Synthase Converts a Proton Gradient Into Energy
Before ATP synthase can do its job, other parts of your cell’s energy machinery have to set the stage. During cellular respiration, a series of protein complexes pump protons from one side of a membrane to the other, creating a buildup of protons on one side. This creates an electrochemical gradient with two components: a difference in proton concentration (more acidic on one side) and a voltage difference across the membrane (positive on the proton-heavy side, negative on the other). Together, these store about 5 kilocalories of usable energy per proton.
Because the membrane itself is impermeable to charged particles, protons can only flow back to the other side through protein channels. ATP synthase provides that channel. As protons stream through it, the enzyme captures their energy and uses it to forge the chemical bond that turns ADP into ATP. This coupling of a proton gradient to ATP production is the core of a process called chemiosmosis, first proposed by Peter Mitchell in 1961.
The Two-Part Structure
ATP synthase has two major sections that work together. The FO portion sits within the membrane and forms the proton channel. The F1 portion extends out from the membrane surface into the surrounding fluid, and this is where ATP is actually assembled. A central stalk connects the two, and a peripheral stalk holds the outer shell of F1 in place so it doesn’t just spin along with everything else.
Inside the FO section, a ring of identical small protein subunits (called the c-ring) sits within the membrane. Next to this ring, a separate subunit called the a-subunit forms two half-channels, passageways that don’t fully cross the membrane on their own. A proton enters through one half-channel, binds to a site on the c-ring, rides around as the ring turns, then exits through the second half-channel on the other side. Each proton that passes through nudges the ring forward by one position, and the cumulative effect is smooth, continuous rotation.
The F1 section looks like a ball made of six protein subunits arranged in alternating pairs: three copies of one type and three of another. Three of these six subunits are catalytic, meaning they’re the ones that actually build ATP. Running through the center of this ball is the central stalk, which rotates along with the c-ring below it. Because the stalk is slightly asymmetric, its rotation pushes each catalytic subunit through a cycle of shape changes that drive ATP production.
The Rotary Catalytic Cycle
The genius of ATP synthase is that it works through mechanical rotation. The central stalk spins clockwise (when viewed from the membrane side during synthesis), and each 120-degree turn completes the production cycle at one of the three catalytic sites. A full 360-degree turn produces three ATP molecules.
Each catalytic site cycles through three distinct shapes as the stalk rotates past it. In one conformation, the site is open and binds ADP and phosphate from the surrounding fluid. In the next, it closes tightly around these ingredients and squeezes them together to form ATP. In the final shape, it opens again and releases the finished ATP molecule. All three sites are active simultaneously but at different stages, so the enzyme is producing ATP in a continuous, assembly-line fashion.
The rotation itself happens in two distinct sub-steps. An 80-degree swing is associated with either binding raw materials or releasing the finished ATP, depending on the direction. A smaller 40-degree swing is the rate-limiting step, the slowest part of the process, and it involves a critical conformational change. During synthesis, this 40-degree rotation creates a high-affinity binding pocket for phosphate, pulling it in tightly so it can be joined to ADP. During the 80-degree step, the site’s grip on ATP loosens dramatically, releasing it into the cell.
Where ATP Synthase Is Found
In human cells, ATP synthase sits in the inner mitochondrial membrane with its F1 head projecting into the mitochondrial matrix. The inner membrane is folded into ridges called cristae, which dramatically increase the surface area available for packing in more copies of the enzyme. The FO portion spans the membrane, allowing protons to flow from the intermembrane space (where they’ve been pumped by the electron transport chain) back into the matrix.
In plant cells, a closely related version of ATP synthase is also found in the thylakoid membranes of chloroplasts, where it uses the proton gradient generated by photosynthesis to make ATP. Bacteria have their own version embedded in the plasma membrane. The basic architecture and rotary mechanism are remarkably similar across all these organisms, reflecting how ancient and essential this enzyme is.
Running in Reverse
ATP synthase is a reversible machine. Under normal conditions in your mitochondria, the strong proton gradient drives rotation in the direction that synthesizes ATP. But when the proton gradient collapses or disappears, the enzyme can run backward: it splits ATP apart (acting as an ATPase) and uses that energy to pump protons across the membrane, rebuilding the gradient. Some bacteria rely on this reverse mode during anaerobic conditions when they lack the oxygen-driven electron transport chain to maintain their proton gradient. The enzyme isn’t a particularly efficient proton pump when running in reverse, but it can keep the gradient alive long enough to power other essential membrane transport processes.
Proton Cost Per ATP
The number of protons required to make one ATP molecule depends on the organism. In mammalian mitochondria, the c-ring contains about 8 subunits, and since one full rotation produces 3 ATP, the ratio works out to roughly 2.7 protons per ATP. Experimental measurements generally report a ratio close to 3 protons per ATP for mitochondria. Chloroplasts have a larger c-ring with 14 subunits, giving a ratio of about 4.7 protons per ATP, experimentally reported as roughly 4. This difference means chloroplast ATP synthase needs more protons to make each ATP molecule, but it can operate at a lower proton gradient.
When ATP Synthase Fails
Genetic mutations affecting ATP synthase cause a group of rare but serious conditions. One of the best characterized is NARP (neuropathy, ataxia, and retinitis pigmentosa), caused by a mutation in the mitochondrial gene encoding part of the FO proton channel. People with NARP typically experience numbness, tingling, or pain in the arms and legs, muscle weakness, balance and coordination problems, and progressive vision loss. Children with the condition often have learning disabilities and developmental delays, while older individuals may develop dementia. Seizures, hearing loss, and heart rhythm abnormalities can also occur.
The severity of NARP depends on something called heteroplasmy, the percentage of mitochondria carrying the mutation. When 70 to 90 percent of a person’s mitochondria have the defective gene, the result is NARP. When the number climbs above 90 to 95 percent, the same mutation typically causes the more severe Leigh syndrome, a devastating neurological condition that usually appears in infancy. This dose-dependent relationship highlights how sensitive cells are to reductions in ATP synthase function, particularly in the brain and nervous system, which consume enormous amounts of ATP.
ATP Synthase as a Drug Target
The essential role of ATP synthase in bacteria has made it a target for antibiotics. Bedaquiline, approved for treating multi-drug-resistant tuberculosis, works by jamming the c-ring of the mycobacterial ATP synthase. The drug binds directly to the c-ring subunits, creating a physical block that prevents the ring from rotating past the a-subunit. It also interferes with the specific amino acid residue on the c-ring that normally hands off protons, cutting off the flow of protons that powers rotation. Researchers have also identified a second binding site on the enzyme’s internal coupling subunit, which normally transmits the mechanical force of c-ring rotation to the catalytic head. By disrupting this communication, bedaquiline attacks ATP production through two independent mechanisms, which helps explain its potency against a pathogen that has evolved resistance to most other antibiotics.
The reason bedaquiline works against tuberculosis bacteria without poisoning human cells is that the c-ring sequences differ enough between species. Human mitochondrial ATP synthase doesn’t bind the drug with the same affinity, providing a therapeutic window that makes the treatment viable.